POAI RSI Chart
Last 7 days
4.9%
Last 30 days
31.5%
Last 90 days
-47.4%
Trailing 12 Months
-45.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.0M | 0 | 0 | 0 |
2023 | 1.4M | 1.5M | 1.8M | 1.8M |
2022 | 1.5M | 1.5M | 1.6M | 1.5M |
2021 | 1.2M | 1.4M | 1.2M | 1.4M |
2020 | 1.5M | 1.3M | 1.3M | 1.3M |
2019 | 1.3M | 1.2M | 1.4M | 1.4M |
2018 | 891.3K | 1.1M | 1.3M | 1.4M |
2017 | 534.8K | 556.2K | 574.1K | 654.8K |
2016 | 600.0K | 451.4K | 500.2K | 456.5K |
2015 | 1.0M | 948.3K | 636.9K | 654.4K |
2014 | 399.1K | 566.5K | 855.9K | 951.6K |
2013 | 317.0K | 442.9K | 499.1K | 479.7K |
2012 | 119.3K | 141.9K | 173.2K | 188.8K |
2011 | 0 | 42.7K | 69.7K | 96.6K |
2009 | 0 | 0 | 0 | 15.7K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | rao veena | acquired | - | - | 3,268 | - |
Apr 05, 2024 | hawryluk matthew | acquired | - | - | 2,368 | - |
Apr 05, 2024 | chung-welch nancy | acquired | - | - | 2,353 | - |
Apr 05, 2024 | nuzum charles lee sr | acquired | - | - | 3,268 | - |
Apr 05, 2024 | handley daniel e | acquired | - | - | 2,353 | - |
Apr 05, 2024 | st. clair gregory sr | acquired | - | - | 3,268 | - |
Oct 02, 2023 | hawryluk matthew | acquired | - | - | 1,875 | - |
Oct 02, 2023 | handley daniel e | acquired | - | - | 1,875 | - |
Oct 02, 2023 | st. clair gregory sr | acquired | - | - | 1,875 | - |
Oct 02, 2023 | rao veena | acquired | - | - | 1,875 | - |
Which funds bought or sold POAI recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | reduced | -17.82 | -20,110 | 35,284 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -14.00 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 12.34 | -1,017 | 6,846 | -% |
May 13, 2024 | NATIONAL BANK OF CANADA /FI/ | new | - | 162 | 162 | -% |
May 13, 2024 | RB Capital Management, LLC | sold off | -100 | -68,547 | - | -% |
May 13, 2024 | UBS Group AG | reduced | -50.64 | -5,198 | 3,221 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 0.3 | -27,450 | 95,858 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | added | 21.16 | -3,000 | 44,000 | -% |
May 10, 2024 | BlackRock Inc. | sold off | -100 | -500 | - | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 3.23 | -20.00 | 82.00 | -% |
Unveiling Predictive Oncology Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Predictive Oncology Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Predictive Oncology Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 25.3% | 419,646 | 335,032 | 715,056 | 490,110 | 239,895 | 363,473 | 455,827 | 371,591 | 314,568 | 476,493 | 313,663 | 350,207 | 280,317 | 293,788 | 480,757 | 182,784 | 294,943 | 347,477 | 522,696 | 286,151 | 255,241 |
Gross Profit | 166.7% | 232,231 | 87,076 | 608,116 | 330,349 | 119,756 | 210,035 | 347,676 | 237,516 | 205,125 | 340,269 | 203,498 | 207,330 | 182,559 | 199,720 | 305,551 | 97,523 | 202,286 | 302,958 | 314,600 | 167,761 | 7,348 |
Operating Expenses | -64.3% | 4,469,003 | 12,515,391 | 842,579 | 993,042 | 878,518 | 24,376,690 | 857,130 | 909,113 | 891,071 | 907,022 | 648,935 | 567,796 | 574,812 | 713,074 | 568,766 | 521,116 | 548,753 | 514,893 | 707,414 | 1,271,258 | 466,566 |
S&GA Expenses | 97.0% | 739,734 | 375,478 | 336,043 | 429,103 | 370,237 | 450,041 | 333,377 | 271,022 | 304,467 | 327,232 | 172,869 | 159,788 | 114,641 | 65,999 | 121,514 | 133,015 | 264,409 | 238,699 | 434,955 | 685,029 | 554,216 |
EBITDA Margin | 8.9% | -12.79 | -14.04 | -13.72 | -15.91 | -17.13 | -16.22 | -11.72 | -12.86 | -12.57 | -12.87 | -19.76 | -17.41 | -19.88 | - | - | - | - | - | - | - | - |
Interest Expenses | -59.6% | 1,737 | 4,296 | 9,608 | - | - | 67.00 | 2,315 | 450 | 989 | -5,481 | 1,554 | - | - | 1,040 | 144,791 | - | - | - | - | - | - |
EBT Margin | 9.2% | -13.13 | -14.46 | -14.23 | -16.61 | -17.99 | -17.10 | -12.55 | -13.76 | -13.97 | -14.30 | -20.91 | -18.42 | -20.91 | - | - | - | - | - | - | - | - |
Net Income | -21.4% | -4,218,843 | -3,475,347 | -3,163,450 | -3,923,368 | -3,421,802 | -7,916,110 | -4,059,484 | -10,391,324 | -3,370,715 | -7,756,512 | -5,438,017 | -2,573,932 | -3,888,713 | -11,469,976 | -6,307,726 | -3,577,378 | -4,529,317 | -14,617,438 | -4,008,512 | 1,465,104 | -1,166,656 |
Net Income Margin | 4.0% | -7.54 | -7.86 | -10.19 | -12.47 | -18.02 | -17.10 | -15.80 | -18.26 | -13.15 | -13.84 | -18.88 | -17.25 | -20.40 | - | - | - | - | - | - | - | - |
Free Cashflow | -11.2% | -3,419,053 | -3,075,064 | -3,108,918 | -3,829,630 | -3,452,130 | -3,292,941 | -2,836,350 | -3,522,283 | -3,139,095 | -3,940,003 | -3,041,471 | -2,424,108 | -3,713,776 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -26.5% | 11.00 | 14.00 | 18.00 | 21.00 | 25.00 | 26.00 | 33.00 | 36.00 | 26.00 | 44.00 | 51.00 | 57.00 | 40.00 | 13.00 | 25.00 | 27.00 | 25.00 | 22.00 | 32.00 | 32.00 | 5.00 |
Current Assets | -34.9% | 7.00 | 10.00 | 14.00 | 16.00 | 20.00 | 23.00 | 27.00 | 30.00 | 26.00 | 29.00 | 43.00 | 46.00 | 28.00 | 2.00 | 3.00 | 4.00 | 4.00 | 1.00 | 1.00 | 1.00 | 4.00 |
Cash Equivalents | -40.5% | 5.00 | 9.00 | 12.00 | 15.00 | 19.00 | 22.00 | 25.00 | 28.00 | 25.00 | 28.00 | 42.00 | 45.00 | 27.00 | 1.00 | 2.00 | 3.00 | 3.00 | 0.00 | 0.00 | 0.00 | 1.00 |
Inventory | -10.7% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net PPE | -11.8% | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 0.00 |
Goodwill | - | - | - | - | - | - | - | - | - | 7.00 | 7.00 | - | 3.00 | 3.00 | 3.00 | 13.00 | 16.00 | 16.00 | 16.00 | 24.00 | 24.00 | 24.00 |
Liabilities | 6.5% | 7.00 | 6.00 | 7.00 | 6.00 | 7.00 | 4.00 | 4.00 | 3.00 | 3.00 | 4.00 | 3.00 | 4.00 | 4.00 | 10.00 | 13.00 | 16.00 | 15.00 | 11.00 | 11.00 | 10.00 | 5.00 |
Current Liabilities | 14.3% | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 9.00 | 12.00 | 15.00 | 12.00 | 11.00 | 11.00 | 9.00 | 5.00 |
Shareholder's Equity | -51.0% | 4.00 | 8.00 | 12.00 | 15.00 | 19.00 | 22.00 | 30.00 | 34.00 | 37.00 | 40.00 | 48.00 | 53.00 | 36.00 | 3.00 | 12.00 | 12.00 | 10.00 | 11.00 | 21.00 | 22.00 | 0.00 |
Retained Earnings | -2.5% | -171 | -167 | -164 | -161 | -157 | -153 | -145 | -141 | -131 | -128 | -120 | -114 | -112 | -108 | -96.91 | -90.61 | -87.03 | -82.50 | -68.94 | -64.94 | -66.40 |
Additional Paid-In Capital | 0.0% | 176 | 176 | 176 | 176 | 176 | 176 | 175 | 175 | 168 | 168 | 167 | 167 | 147 | 111 | 109 | 102 | 97.00 | 94.00 | 90.00 | 87.00 | 66.00 |
Shares Outstanding | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 19.00 | - | - | - | 32.00 | - | - | - | 86.00 | - | - | - | 32.00 | - | - | - | 20.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -10.8% | -3,416 | -3,082 | -3,105 | -3,574 | -3,427 | -3,234 | -2,708 | -3,334 | -3,093 | -3,744 | -2,937 | -2,204 | -3,322 | -2,303 | -3,232 | -3,748 | -2,972 | -2,795 | -1,891 | -1,996 | -2,048 |
Share Based Compensation | -37.7% | 734* | 1.00 | -14.30 | 6.00 | 9.00 | 63.00 | 27.00 | 39.00 | 37.00 | 89.00 | 29.00 | 33.00 | 565 | 164 | 135 | 135 | 288 | 246 | 360 | 1,381 | 264 |
Cashflow From Investing | -141.6% | -3.03 | 7.00 | -3.92 | -259 | -46.64 | -63.60 | -143 | -188 | -80.24 | -9,787 | -186 | -240 | -393 | -141 | -116 | 122 | -32.51 | -7.33 | -10.84 | 44.00 | -624 |
Cashflow From Financing | -0.9% | -112 | -111 | 260 | - | - | -23.63 | -4.03 | 6,656 | 87.00 | -37.49 | 15.00 | 20,027 | 30,336 | 649 | 2,429 | 3,963 | 5,911 | 2,855 | 1,931 | 898 | 3,636 |
Buy Backs | -100.0% | - | 2.00 | - | - | - | 24.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Assets, Current [Abstract] | ||
Cash | $ 5,197,235 | $ 8,728,660 |
Accounts receivable | 509,445 | 333,697 |
Inventories | 441,718 | 494,374 |
Prepaid expense and other assets | 412,925 | 521,700 |
Total current assets | 6,561,323 | 10,078,431 |
Property and equipment, net | 1,087,718 | 1,233,910 |
Intangibles, net | 245,594 | 252,457 |
Lease right-of-use assets | 2,582,456 | 2,728,355 |
Other long-term assets | 124,096 | 124,096 |
Total assets | 10,601,187 | 14,417,249 |
Current liabilities: | ||
Accounts payable | 1,729,126 | 1,342,027 |
Note payable | 38,036 | 150,408 |
Accrued expenses and other liabilities | 1,904,612 | 1,631,702 |
Derivative liability | 367 | 1,376 |
Contract liabilities | 304,320 | 308,091 |
Lease liability | 540,200 | 517,427 |
Total current liabilities | 4,516,661 | 3,951,031 |
Other long-term liabilities | 3,507 | 5,459 |
Lease liability – net of current portion | 2,027,348 | 2,188,979 |
Total liabilities | 6,547,516 | 6,145,469 |
Commitments and Contingencies | ||
Stockholders’ equity: | ||
Common stock, $.01 par value, 200,000,000 shares authorized, 4,062,853 shares outstanding as of March 31, 2024, and December 31, 2023 | 40,629 | 40,629 |
Additional paid-in capital | 175,992,976 | 175,992,242 |
Accumulated deficit | (171,980,726) | (167,761,883) |
Total stockholders’ equity | 4,053,671 | 8,271,780 |
Total liabilities and stockholders’ equity | 10,601,187 | 14,417,249 |
Series B Convertible Preferred Stock [Member] | ||
Stockholders’ equity: | ||
Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of March 31, 2024, and December 31, 2023 | $ 792 | $ 792 |